Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2013 Sep 18;20(0 3):S725–S730. doi: 10.1245/s10434-013-3262-5

FIG. 3.

FIG. 3

Comparison of the overall (a) and disease-free (b) survival for individuals with total lymphocyte counts (TLC) <500 cells/mm3 versus those with TLC of ≥ 500 cells/mm3 immediately before the second vaccine (i.e., after adjuvant chemoradiation)